Evidence map›Paper›PMID 40379274›Full record

ArticleBMJ global health2025

Clustering and visualisation of the GABRIEL network expertise in the field of infectious diseases.

Cécile Chauvel, Philippe Vanhems, Marie-Charlotte Quemin, Marianne Abifadel, Shally Awasthi, Sayera Banu, Silvia Figueiredo Costa, Sara Eyangoh, Monzer Hamze, Zakir Hossain and 15 more

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Cécile ChauvelCenter of Excellence in Respiratory Pathogens, Hospices Civils de Lyon, Lyon, France.
Philippe VanhemsÉquipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses, Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France.
Marie-Charlotte QueminFondation Mérieux, Lyon, France.
Marianne AbifadelRodolphe Mérieux Laboratory, Faculty of Pharmacy, Saint Joseph University of Beirut, Beirut, Lebanon.
Shally AwasthiDepartment of Pediatrics, King George's Medical University, Lucknow, India.
Sayera BanuInternational Centre for Diarrheal Disease Research, Dhaka, Bangladesh.
Silvia Figueiredo CostaTropical Medicine Institute of Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.
Sara EyangohCentre Pasteur du Cameroun, Yaounde, Cameroon.
Monzer HamzeLaboratoire Microbiologie Santé et Environnement, Faculty of public Health, Lebanese University, Tripoli, Lebanon.
Zakir HossainRodolphe Merieux Laboratory, Bangladesh Institute of Tropical and Infectious Disease, Chittagong, Bangladesh.
Bourema KouribaCharles Merieux Center of Infectiology, Bamako, Mali.ORCID http://orcid.org/0000-0002-3419-5972
Daniel Mukadi-BamulekaRodolphe Merieux Laboratory, Institut National de Recherche Biomédicale, Goma, République démocratique du Congo.
Francine NtoumiFondation Congolaise pour la Recherche Médicale, Brazzaville, République du Congo.
Abdoul-Salam OuedraogoLaboratoire des Pathogènes Emergents et Ré-émergents, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.
Phimpha PaboribouneCenter of Infectiology Lao - Christophe Mérieux, Ventiane, Lao People's Democratic Republic.
Jean William PapeLes Centres GHESKIO, Port-au-Prince, Haiti.
Chan Leakhena PhoeungRodolphe Merieux Laboratory, University of Health Sciences, Phnom Penh, Cambodia.ORCID http://orcid.org/0000-0002-6538-3597
Firdausi QadriInstitute for developing Science and Health Initiatives, Dhaka, Bangladesh.ORCID http://orcid.org/0000-0002-4158-5995
Ana Tereza Ribeiro VasconcelosBioinformatics Laboratory, National Laboratory of Scientific Computing, Petropolis, Brazil.
Graciela RussomandoInstituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay.
Luc SamisonCharles Mérieux Center for Infectious Diseases, University of Antananarivo, Antananarivo, Madagascar.
Marilda Agudo Mendonça SiqueiraOswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Nestani TukvadzeNational Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia.
Jianwei WangChristophe Mérieux Laboratory, Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Pathogen Biology, Beijing, China.
Florence Komurian PradelFondation Mérieux, Lyon, France florence.pradel@fondation-merieux.org.ORCID http://orcid.org/0000-0002-1023-0796

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Global Approach to Biology Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) network is an international scientific network of 21 centres coordinated by the Merieux Foundation (Lyon, France). Mapping and characterising the similarities and differences in expertise and activities across four major infectious diseases (tuberculosis, antimicrobial-resistant infections, acute respiratory infections and emerging pathogens) among these centres would help to provide a better understanding of the network's capacity. It will also highlight how the applied methodology can enhance information sharing within research networks.

methodsEach centre responded to a questionnaire on their core activities and research themes. An advanced multivariate analysis was performed to relate all items together and highlight new synergies among members of the GABRIEL network. Similarities were found using a clustering algorithm and data were visualised using alluvial plots.

resultsThis strategy enabled to find new patterns in the GABRIEL network for the implementation of new projects on global health, regardless of geographical proximity or historical connections. Five clusters based on core activities, consisting of 6, 1, 3, 9 and 2 research units, respectively, have been identified, with clusters 1 and 4, including the majority of the units. Four clusters have been defined based on the four major infectious diseases, comprising 7, 3, 5 and 6 research units, respectively.

conclusionsThe same methodology could also be applied to identify proximities on other networks of experts or between members of different networks for more efficient research or surveillance global programmes.

Indexed as

Communicable DiseasesCluster AnalysisDeveloping CountriesFranceGlobal HealthHumansInternational CooperationSurveys and QuestionnairesGlobal HealthInfections, diseases, disorders, injuries

Identifiers

PMID40379274
PMCPMC12086879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.